Sales
COVID-19 alters GP and pharmaceutical field staff engagement – according to survey
With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement.
The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders.
It shows prior to the pandemic half of GPs would see a rep at least once a month or more, however, in the wake of social distancing measures, 79% of GPs have not been contacted and only 5% have reported a visit in person.
Instead, GPs have seen increases in field staff attempting to contact them by phone (22% compared with 16% last year) along with email which has also risen to 37% (up from 30% last year).
While these changes may be expected, a more surprising results was the uplift in video conferencing, that moved from only 1% of GP using it pre-COVID to 5% during the pandemic.
But, when combined with the increase in Live Chat, 13% of GPs responded with these virtual solutions as their preferred way of being contacted in the future (up from 3% pre-COVID). At the same time, in-person field staff visits have dropped from 81% to 50% preferring this contact form post-COVID.
Recently, Medicines Australia’s released guidance around field staff returning to practices, urging the need to be agile and flexible when working with their healthcare professional colleagues. When asked if they agreed with this approach, 43% of GPs said they did, with only 4% saying they did not.
Medicines Australia CEO Elizabeth de Somer congratulated field staff on their responsiveness to the crisis “At the outset of industry’s response to the COVID-19 crisis, members reacted quickly to protect the safety of our sales forces and those they interact with by reducing face-to-face interactions with healthcare professionals.
“The educational interaction between a healthcare professional and a pharmaceutical field rep is an important reciprocal relationship and we are pleased that this will continue under our new normal,” said Ms de Somer.
“Healthcare professionals and clinicians have adopted virtual meetings widely, and this positive survey result is validation that this is appreciated,” said Ms de Somer.
News & Trends - MedTech & Diagnostics
Roche Diagnostics MD bids farewell after two-decades, leading the organisation to new heights of success
Diagnostics & MedTech News: The Managing Director of Roche Diagnostics Australia, Allison Rossiter, has announced her resignation, effective September 2024. […]
MoreNews & Trends - Pharmaceuticals
Is Australia ready to play a leading role in precision nuclear medicines?
Pharma News: A newly released discussion paper unveils Australia’s preparedness to take the helm in the rise of the global […]
MoreNews & Trends - MedTech & Diagnostics
Minimally invasive procedure a first in epilepsy treatment
MedTech & Diagnostics News: An Australian-first procedure utilising MRI-guided, minimally invasive surgery has been introduced for the treatment of epilepsy […]
MoreNews & Trends - Pharmaceuticals
Stakeholders unite in international call to tackle breast cancer gaps and inequities
Pharma News: Breast Cancer Network Australia (BCNA) has united in an international call to raise breast cancer care standards and […]
More